mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.002 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |